Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Antares Certificates | ANT | Apr 29, 2024 | 7.00 | 0.00 |
APERAM | APAM | Apr 29, 2024 | 28.00 | +0.36 |
Argen X SE | ARGX | Apr 29, 2024 | 348.50 | -0.23 |
Ascencio Sca | ASC | Apr 29, 2024 | 50.90 | 0.00 |
Ascencio Sca | ASCE | Apr 29, 2024 | 48.70 | +0.31 |
ASIT biotech SA | ASIT | Apr 29, 2024 | 0.23 | 0.00 |
Assicurazioni Generali SpA | GEN | Apr 29, 2024 | 19.50 | 0.00 |
Atenor | ATEB | Apr 29, 2024 | 5.98 | -1.32 |
AVANTIUM | AVTX | Apr 29, 2024 | 2.60 | +3.80 |
Azelis Group NV | AZE | Apr 29, 2024 | 23.16 | +1.94 |
Balta Group N.V. | BALTA | Apr 29, 2024 | 1.36 | 0.00 |
Banco Bilbao Vizcaya Argentaria SA | BBV | Apr 29, 2024 | 7.80 | 0.00 |
Banco Santander SA | SANTA | Apr 29, 2024 | 3.58 | 0.00 |
Banimmo SA | BANI | Apr 29, 2024 | 3.76 | +1.08 |
Banque Nationale de Belgique | BNB | Apr 29, 2024 | 456.00 | -0.22 |
Barco NV | BAR | Apr 29, 2024 | 12.98 | -0.92 |
Basilix | BAS | Apr 29, 2024 | 13.50 | 0.00 |
Beaulieu Av Certificates | BEAB | Apr 29, 2024 | 1.19 | 0.00 |
Befimmo SA | BEFB | Apr 29, 2024 | 46.10 | 0.00 |
Bel20 | BEL20 | Apr 29, 2024 | 3 886.76 | +0.31 |
Belreca - Belgian Resources and Capital Company | BELR | Apr 29, 2024 | 7.50 | 0.00 |
Beluga NV | BELU | Apr 29, 2024 | 1.19 | 0.00 |
Belysse Group N.V. | BELYS | Apr 29, 2024 | 0.82 | -2.94 |
Biocartis Group NV | BCART | Apr 29, 2024 | 0.29 | 0.00 |
Biosenic | BIOS | Apr 29, 2024 | 0.02 | 0.00 |
Biotalys | BTLS | Apr 29, 2024 | 3.04 | +1.33 |
Boeing | BOEI | Apr 29, 2024 | 224.00 | 0.00 |
Bone Therapeutics S.A. | BOTHE | Apr 29, 2024 | 0.29 | 0.00 |
Bpost S.A. / N.V | BPOST | Apr 29, 2024 | 3.76 | +0.94 |
Brederode S.A. | BREB | Apr 29, 2024 | 113.20 | +0.89 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.